Department of Medical Nursing, Jiyuan Vocational and Technical College, 459000 Jiyuan, Henan, P.R. China.
Comb Chem High Throughput Screen. 2024;27(11):1551-1565. doi: 10.2174/0113862073257733231011072004.
The relationship between gut microbiota and bioactive components has become the research focus in the world. We attempted to clarify the relationship between biotransformation and metabolites of gut microbiota and bioactive components, and explore the metabolic pathway and mechanism of bioactive ingredients , which will provide an important theoretical basis for the clinical research of bioactive ingredients and rationality of drugs, and also provide an important reference for the development of new drugs with high bioavailability.
The related references of this review on microbiota and bioactive components were collected from both online and offline databases, such as ScienceDirect, PubMed, Elsevier, Willy, SciFinder, Google Scholar, Web of Science, Baidu Scholar, SciHub, Scopus, and CNKI.
This review summarized the biotransformation of bioactive components under the action of gut microbiota, including flavonoids, terpenoids, phenylpropanoids, alkaloids, steroids, and other compounds. The interaction of bioactive components and gut microbiota is a key link for drug efficacy. Relevant research is crucial to clarify bioactive components and their mechanisms, which involve the complex interaction among bioactive components, gut microbiota, and intestinal epithelial cells. This review also summarized the individualized, precise, and targeted intervention of gut microbiota in the field of intestinal microorganisms from the aspects of dietary fiber, microecological agents, fecal microbiota transplantation, and postbiotics. It will provide an important reference for intestinal microecology in the field of nutrition and health for people.
To sum up, the importance of human gut microbiota in the research of bioactive components metabolism and transformation has attracted the attention of scholars all over the world. It is believed that with the deepening of research, human gut microbiota will be more widely used in the pharmacodynamic basis, drug toxicity relationship, new drug discovery, drug absorption mechanism, and drug transport mechanism in the future.
肠道微生物群与生物活性成分的关系已成为世界范围内的研究热点。我们试图阐明肠道微生物群与生物活性成分的生物转化和代谢物之间的关系,并探索生物活性成分的代谢途径和机制,这将为生物活性成分的临床研究和药物的合理性提供重要的理论基础,也为开发具有高生物利用度的新药提供重要参考。
本综述通过在线和离线数据库(如 ScienceDirect、PubMed、Elsevier、Willy、SciFinder、Google Scholar、Web of Science、百度学术、SciHub、Scopus 和中国知网)收集了关于肠道微生物群和生物活性成分的相关参考文献。
本综述总结了生物活性成分在肠道微生物群作用下的生物转化,包括类黄酮、萜类、苯丙素类、生物碱、甾体等化合物。生物活性成分与肠道微生物群的相互作用是药物疗效的关键环节。相关研究对于阐明生物活性成分及其机制至关重要,涉及生物活性成分、肠道微生物群和肠上皮细胞之间的复杂相互作用。本综述还从膳食纤维、微生态制剂、粪便微生物移植和后生元等方面总结了肠道微生物群在肠道微生物领域对个体化、精准和靶向干预的影响。这将为营养与健康领域的肠道微生态提供重要参考。
总之,人类肠道微生物群在生物活性成分代谢和转化研究中的重要性引起了全世界学者的关注。相信随着研究的深入,人类肠道微生物群在未来将更广泛地应用于药效学基础、药物毒性关系、新药发现、药物吸收机制和药物转运机制。